Navigation Links
Multiple Clinical Trials of VELCADE(R) (Bortezomib) for Injection Based Therapies Demonstrate High Complete Remission Rates in Patients with Newly Diagnosed Multiple Myeloma
Date:5/31/2008

t. After median follow up of 13.6 months, median progression-free survival and overall survival have not been reached. Side effects were manageable and included hematologic toxicity and peripheral neuropathy.

Safety and Efficacy of Lenalidomide, VELCADE and dexamethasone in Patients with Newly Diagnosed Multiple Myeloma: A Phase I/II Study (Abstract #8520)

This Phase I/II study of VcRD combination therapy was designed to determine the maximum tolerated dose (MTD) and efficacy in previously untreated MM patients. The preliminary analysis included 66 evaluable patients, who received VELCADE at 1.0 mg/m2 or 1.3 mg/m2 on days 1, 4, 8 and 11 of a 21-day schedule. Patients also received lenalidomide at 15, 20 or 25 mg on days 1 through 14 and dexamethasone at 40 or 20 mg on the day of and day after each VELCADE dose. Patients were treated for up to eight cycles at four planned dose levels. Maximum planned dose was VELCADE 1.3 mg/m2, lenalidomide 25 mg and dexamethasone 20 mg. Response was assessed by modified EBMT criteria and International Myeloma Working Group criteria. Results were presented by Paul Richardson, M.D., Associate Professor of Medicine, Harvard Medical School; Clinical Director, Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Boston and showed a CR rate of 35 percent at maximum planned dose and a 100 percent overall response rate (CR + partial response). Side effects were manageable and included lymphopenia, thrombocytopenia, hypophosphatemia and neutropenia. No grade 4 peripheral neuropathy was observed.

About Multiple Myeloma

Multiple myeloma is the second most common hematologic malignancy and although the disease is predominantly a cancer of the elderly (the median age of onset is 70 years), recent statistics indicate both increasing incidence and younger age of onset. In the U.S., more than 50,000 individuals have MM and 20,000 new cases are diagnosed each year. Worldwide there are approximately 74,000
'/>"/>

SOURCE Millennium Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
2. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
3. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
4. Kosan Opens Registration Program for Lead Hsp90 Inhibitor, Tanespimycin, in Multiple Myeloma
5. Multiple NIH Phase 2 HIV Vaccine Trials Using Vicals Technology Produce Encouraging Results
6. TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel
7. Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma
8. TorreyPines Therapeutics Completes Phase I Multiple Dose Clinical Trial of NGX267, a Selective M1 Agonist for the Potential Treatment of Cognitive Impairment Associated with Schizophrenia
9. Pharmacopeia Announces Positive Results from Phase 1 Multiple Ascending Dose Study of PS433540 (DARA)
10. Phase III Clinical Trial in Newly Diagnosed Multiple Myeloma Stopped Early Due to Highly Significant Efficacy Advantage of VELCADE(R) (Bortezomib) for Injection Based Therapy Across All Endpoints
11. Velcura Therapeutics, Inc. Reports Positive Pre-IND Meeting With FDA and Plans Early Clinical Trials for New Drug to Treat Multiple Myeloma Bone Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/26/2015)... March 26, 2015 Huntington Memorial Hospital is ... perform transcatheter aortic valve replacement (TAVR), a minimally invasive ... revolutionary new way to replace an aortic valve without ... lung machine. The procedure is performed by ... Azhil ( Alex) Durairaj , MD, interventional cardiologist and ...
(Date:3/26/2015)... S.C. , March 26, 2015 ... told by their existing PACS vendor their system ... (CMH) determined that they needed a better structured ... Hospital selected Avreo interWORKS due to its interface ... modern meaningful use standards through to the hospital,s ...
(Date:3/26/2015)... , March 26, 2015  Desert Valley Medical ... five times , is the first U.S. hospital ... its emergency department to help clinicians prevent hospital acquired ... Victorville, Calif. , is a community hospital ... patients.  Using the Leaf Patient Monitor in the hospital,s ...
Breaking Medicine Technology:Huntington Memorial Hospital Performs Groundbreaking Minimally Invasive Replacement of Heart Valves 2Clinch Memorial Hospital Modernizes Workflow with Avreo interWORKS 2Desert Valley Medical Center First to Use Leaf Healthcare Patient Wearable Technology in its ED as Part of Hospital-wide Deployment 2Desert Valley Medical Center First to Use Leaf Healthcare Patient Wearable Technology in its ED as Part of Hospital-wide Deployment 3
(Date:3/27/2015)... (PRWEB) March 27, 2015 The report ... an essential source of information on and analysis of ... The population of the US in 2013 amounted to ... Rate (CAGR) of 0.8% from 2008. The country’s increasingly ... chronic diseases will help to boost the growth of ...
(Date:3/27/2015)... 27, 2015 GrassrootsHealth, an international nonprofit ... Children (POC) NOW! vitamin D demonstration project April 7 ... South Carolina (MUSC), and will soon follow with a ... no cost to a minimum of 500 pregnant women ... these two service areas. The project will include patient ...
(Date:3/27/2015)... Trail mix is the perfect, healthy snack for families ... during the game! It’s portable, lightweight and provides a wide ... a new line of specialty trail mixes that satisfy your ... packed with nutritious, 100% all natural ingredients. , These tasty ... protein and fiber to your diet and boost energy. The ...
(Date:3/27/2015)... (PRWEB) March 27, 2015 Since September 2014, ... in his comeback tour after having been in retirement for ... eager for the performer to return to touring, and concert ... tickets for Omaha will likely sell out for the two ... BuyCheapTicketsToEvents.com to view the inventory of discounted Garth ...
(Date:3/27/2015)... April 2015 is the 150th anniversary of ... honor America’s bloodiest war and the amazing President that led ... Tribute to the Civil War and Abraham Lincoln. This moving ... at the Jane Pickens Theater in Newport, RI. , ... serve as the master of ceremonies. Dr. Fred Zilian, educator, ...
Breaking Medicine News(10 mins):Health News:US Pharmaceutical Market worth $548.4 billion by 2020 Says a New Report Available at RnRMarketResearch.com 2Health News:US Pharmaceutical Market worth $548.4 billion by 2020 Says a New Report Available at RnRMarketResearch.com 3Health News:US Pharmaceutical Market worth $548.4 billion by 2020 Says a New Report Available at RnRMarketResearch.com 4Health News:GrassrootsHealth Moves Vitamin D into Practice with Pregnant Women 2Health News:GrassrootsHealth Moves Vitamin D into Practice with Pregnant Women 3Health News:GrassrootsHealth Moves Vitamin D into Practice with Pregnant Women 4Health News:Aurora Product, Inc. Introduces New Line of Specialty Trail Mixes 2Health News:Garth Brooks Tickets for Omaha: BuyCheapTicketsToEvents.com Draws Customers by Discounting Prices on 2015 Tickets for Garth Brooks’ Tour Stops at CenturyLink Center 2Health News:Relive the Civil War, the Presidency and Shocking Assassination of Abraham Lincoln through Lincoln’s Own Words and the Music of a 46-Piece Orchestra 2Health News:Relive the Civil War, the Presidency and Shocking Assassination of Abraham Lincoln through Lincoln’s Own Words and the Music of a 46-Piece Orchestra 3Health News:Relive the Civil War, the Presidency and Shocking Assassination of Abraham Lincoln through Lincoln’s Own Words and the Music of a 46-Piece Orchestra 4
... Exposure to secondhand smoke, even at extremely low levels, ... new research being presented Sunday, May 1, at the Pediatric ... with elevated blood pressure are at increased risk of having ... with a higher risk of heart and kidney disease and ...
... now have a tailored approach to dental hygiene for ... team of nurses. "Poor oral health can lead to ... said Rita A. Jablonski, even though these illnesses are ... assistant professor of nursing, Penn State, persons with dementia ...
... 29 (HealthDay News) -- Medical costs for children and teens ... people in the United States, a new study finds. ... examined health insurance claims made in 2007 for nearly 50,000 ... Annual medical expenses for youth with diabetes were $9,061, compared ...
... show up in the emergency department (ED) complaining primarily ... should be tested for sexually transmitted infections (STIs), according ... Saturday, April 30, at the Pediatric Academic Societies (PAS) ... shown that when adolescents seek treatment for symptoms suggestive ...
... Minn. -- Robotic surgery has become a mainstream tool for ... a team of head and neck surgeons from Mayo Clinic ... hard-to-reach area beyond the tongue at the top of the ... treatment with chemotherapy or radiation, and most could resume normal ...
... Dr. Paul Sanberg, Distinguished University Professor and ... the University of South Florida, received the Everfront Award ... and Cancer Research held earlier this month in Taichung, ... in stem cell and cancer research, including pre-clinical, clinical ...
Cached Medicine News:Health News:Living with a smoker may raise blood pressure in boys 2Health News:Dirty mouths lead to broken hearts 2Health News:EDs should be aware of sexually transmitted infection risk in patients 2Health News:Mayo Clinic finds robotic surgery effective for removing hard-to-reach throat cancer 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: